How Will The Point Of Care Infectious Disease Testing Market Expand At A CAGR Of 13.6% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Point Of Care Infectious Disease Testing Market?
The market size for point of care infectious disease testing has witnessed exponential growth in recent years. It is predicted to escalate from $4.21 billion in 2024 to $4.78 billion in 2025, representing a compound annual growth rate (CAGR) of 13.6%. Factors contributing to such historic growth include the growing need for rapid diagnostic procedures, the increasing occurrence of infectious diseases, enhanced healthcare awareness, increased healthcare spending, and the rise of home care and self-testing solutions.
In the upcoming years, the market size for point of care infectious disease testing is expected to experience notable growth. By 2029, it is projected to reach $7.96 billion, with a compound annual growth rate (CAGR) of 13.6%. Several factors contributing to this growth in the forecast period include increased demand for swift diagnostics, a rise in the occurrence of infectious diseases, greater usage in remote and resources-restricted environments, a transition towards decentralized healthcare, and aid from government initiatives and funding. Top trends during the forecast period encompass progress in molecular diagnostics, improved point of care testing apparatus, innovations in biosensors and detection techniques, advancements in mobile health applications, and inventive collaborations between health service providers and technology firms.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp
What Drivers Are Accelerating Expansion Of The Point Of Care Infectious Disease Testing Market?
The burgeoning spread of infectious diseases is anticipated to fuel the expansion of the point of care infectious disease testing market. Contagious diseases, those communicable from person to person through direct contact, airborne droplets, or other transmission means, seem to be increasing due to enhanced human mobility. This movement across regions and countries accelerates the distribution of infectious agents. Testing infectious diseases at their point of care fast tracks detection and diagnosis, leading to early treatments and minimizing community spread. As an example, the UK Health Security Agency reported in June 2024 that 1,681 critical care admissions due to confirmed influenza between week 40 of 2022 and week 15 of 2023 occurred in 108 NHS trusts in England. This was a significant rise from the previous flu season which saw just 182 admissions across 114 trusts, a figure that increased to 316 by week 39 of 2022. As a result, the increasing spread of infectious diseases is pushing the growth of the point of care infectious disease testing market.
What Are The Primary Segmentation Parameters In The Point Of Care Infectious Disease Testing Market?
The point of care infectious disease testingmarket covered in this report is segmented –
1) By Product: Kits And Reagents; Instruments
2) By Technology: Lateral Flow Immunoassay; Agglutination Test; Flow-through Test Or Immunoconcentration Assay; Molecular Diagnostics; Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing; Clostridium Difficile Point-of-Care Testing; Hepatitis B Virus Point-of-Care Testing; Pneumonia or Streptococcus Associated Infections; Respiratory Syncytial Virus Point-of-Care Testing; Human Papillomavirus Point-of-Care Testing; Influenza Or Flu Point-of-Care Testing; Other Diseases
4) By End Use: Hospitals; Diagnostic Centers; Research and Academic Institutes; Homecare Settings; Other End Users
Subsegments:
1) By Kits And Reagents: Test Kits; Reagents
2) By Instruments: Portable Devices; Automated Analyzers
How Are Industry Trends Steering The Expansion Of The Point Of Care Infectious Disease Testing Market?
Leading businesses in the point-of-care infectious disease testing market are prioritizing the integration of cutting-edge technologies, including proprietary microfluidic technology. This technology is geared towards enhancing the accuracy of tests, minimizing the time to return results, and boosting patient outcomes. Proprietary microfluidic technology pertains to specialized systems that handle small fluid volumes at the microscale, enabling swift, accurate, and affordable analysis. This technology aids point-of-care (POC) infectious disease testing through immediate, on-site pathogen detection, which integrates sample collection, analysis, and result delivery, thereby accelerating diagnosis and accessibility without requiring centralized lab testing. For example, Sysmex Corporation, a diagnostics firm from Japan, in June 2023, introduced the PA-100 AST System in Europe, marking the first global point-of-care testing solution for direct detection of antimicrobial susceptibility. With the deployment of advanced microfluidic technology, this system is capable of quickly identifying bacterial infections and assessing the effectiveness of antimicrobials, greatly diminishing processing time compared to traditional procedures. The system, which is compact and desktop-sized with single-use sample cartridges, is apt for near-patient settings like primary care clinics. The system aids in making swifter and more accurate decisions concerning antimicrobial treatment, thereby boosting diagnostic efficiency and contributing to the worldwide fight against antimicrobial resistance.
Which Players Are Shaping The Competitive Landscape Of The Point Of Care Infectious Disease Testing Market?
Major companies operating in the point of care infectious disease testing market are Cardinal Health, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, bioMérieux Société Anonyme, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin Società per Azioni, Danaher Corporation, Cue Health Inc., Nova Biomedical Corporation, Seegene Incorporated, Biosynex Société Anonyme, Trivitron Healthcare Private Limited, EKF Diagnostics Holdings plc, Trinity Biotech Public Limited Company, bioLytical Laboratories Inc.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Point Of Care Infectious Disease Testing Market?
North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=24382&type=smp
Browse Through More Reports Similar to the Global Point Of Care Infectious Disease Testing Market 2025, By The Business Research Company
Veterinary Point Of Care Diagnostics Global Market Report 2025
Point Of Care Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Point Of Care Ultrasound Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/point-of-care-ultrasound-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
